Intrinsic Capital Partners, a Conshohocken, Pa.-based private equity firm, closed a $102m growth equity fund.
Intrinsic Health Partners, L.P., invests in life science and technology businesses focusing on ancillary life science and technology companies that support the broader cannabis and hemp industries.
Founded by principals Gerald Stahlecker, Cornelius Merlini and Goodwin, Intrinsic focuses on ancillary cannabis and hemp businesses. Key to the firm’s strategy is its deep network of operating advisors who bring decades of experience in healthcare, technology, consumer marketing and regulatory affairs. The advisors have engaged in supporting investment and segment diligence, regulatory evaluations and market risk assessments. They are also actively engaged in building and scaling Intrinsic’s portfolio companies, either as board directors or members of management.
Intrinsic’s operator-centric investment model leverages a network of veterans of the consumer, life sciences and technology industries. This advisory group includes:
- Bill McComb, formerly CEO of Liz Claiborne, Inc., Company Group Chairman for DePuy Orthopedics within Johnson & Johnson, and President of McNeil Consumer Healthcare;
- Minnie Baylor-Henry, formerly Director, DDMAC, of the FDA, National Health Fraud Coordinator of the FDA, Worldwide VP of Regulatory Affairs for Medical Devices & Diagnostics within Johnson & Johnson, and VP of Medical & Regulatory Affairs for McNeil Consumer Healthcare;
- Bob Sheroff, formerly Global Head of Supply Chain across multiple divisions within Johnson & Johnson, including Global Biologics at Jansen, and World-Wide VP of Quality at Warner Lambert; and
- Bob Miller, Ph.D., formerly SVP of Gilead Sciences, Inc. and Head of Quality across multiple divisions of Johnson & Johnson.
To date, Intrinsic has committed $65m to four portfolio company investments, including ACT Laboratories, Inc. (lab testing), Treez, Inc. (business management software), Hound Labs, Inc. (marijuana and alcohol breathalyzer technology) and Elemental Brands, Inc. (hemp-derived consumer healthcare products).
FinSMEs
11/11/2020